Literature DB >> 25152487

KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar ataxia 13 displays aberrant intracellular trafficking.

Carolina Gallego-Iradi1, Justin S Bickford2, Swati Khare1, Alexis Hall1, Jerelyn A Nick1, Donya Salmasinia1, Kolja Wawrowsky3, Serguei Bannykh4, Duong P Huynh5, Diego E Rincon-Limas1, Stefan M Pulst5, Harry S Nick2, Pedro Fernandez-Funez6, Michael F Waters7.   

Abstract

<span class="Disease">Spinocerebellar ataxia 13 (SCA13) is an <span class="Disease">autosomal dominant disease resulting from mutations in KCNC3 (Kv3.3), a voltage-gated potassium channel. The KCNC3(R420H) mutation was first identified as causative for SCA13 in a four-generation Filipino kindred with over 20 affected individuals. Electrophysiological analyses in oocytes previously showed that this mutation did not lead to a functional channel and displayed a dominant negative phenotype. In an effort to identify the molecular basis of this allelic form of SCA13, we first determined that human KCNC3(WT) and KCNC3(R420H) display disparate post-translational modifications, and the mutant protein has reduced complex glycan adducts. Immunohistochemical analyses demonstrated that KCNC3(R420H) was not properly trafficking to the plasma membrane and surface biotinylation demonstrated that KCNC3(R420H) exhibited only 24% as much surface expression as KCNC3(WT). KCNC3(R420H) trafficked through the ER but was retained in the Golgi. KCNC3(R420H) expression results in altered Golgi and cellular morphology. Electron microscopy of KCNC3(R420H) localization further supports retention in the Golgi. These results are specific to the KCNC3(R420H) allele and provide new insight into the molecular basis of disease manifestation in SCA13.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dominant inheritance; Golgi; KCNC3; Protein trafficking; SCA13; Spinocerebellar ataxia; Voltage-gated potassium channel

Mesh:

Substances:

Year:  2014        PMID: 25152487      PMCID: PMC4181561          DOI: 10.1016/j.nbd.2014.08.020

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  35 in total

Review 1.  Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing.

Authors:  B Rudy; C J McBain
Journal:  Trends Neurosci       Date:  2001-09       Impact factor: 13.837

Review 2.  Vertebrate protein glycosylation: diversity, synthesis and function.

Authors:  Kelley W Moremen; Michael Tiemeyer; Alison V Nairn
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-22       Impact factor: 94.444

3.  Dendritic Kv3.3 potassium channels in cerebellar purkinje cells regulate generation and spatial dynamics of dendritic Ca2+ spikes.

Authors:  Edward Zagha; Satoshi Manita; William N Ross; Bernardo Rudy
Journal:  J Neurophysiol       Date:  2010-03-31       Impact factor: 2.714

4.  Complex oligosaccharides are N-linked to Kv3 voltage-gated K+ channels in rat brain.

Authors:  Tara A Cartwright; Melissa J Corey; Ruth A Schwalbe
Journal:  Biochim Biophys Acta       Date:  2006-12-06

5.  Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.

Authors:  Michael F Waters; Natali A Minassian; Giovanni Stevanin; Karla P Figueroa; John P A Bannister; Dagmar Nolte; Allan F Mock; Virgilio Gerald H Evidente; Dominic B Fee; Ulrich Müller; Alexandra Dürr; Alexis Brice; Diane M Papazian; Stefan M Pulst
Journal:  Nat Genet       Date:  2006-02-26       Impact factor: 38.330

6.  Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment.

Authors:  Stephen B Long; Xiao Tao; Ernest B Campbell; Roderick MacKinnon
Journal:  Nature       Date:  2007-11-15       Impact factor: 49.962

Review 7.  Emerging pathogenic pathways in the spinocerebellar ataxias.

Authors:  Kerri M Carlson; J Michael Andresen; Harry T Orr
Journal:  Curr Opin Genet Dev       Date:  2009-04-01       Impact factor: 5.578

8.  Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.

Authors:  Anne McMahon; Stephen C Fowler; Teresa M Perney; Walther Akemann; Thomas Knöpfel; Rolf H Joho
Journal:  Eur J Neurosci       Date:  2004-06       Impact factor: 3.386

9.  Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors.

Authors:  Martina Wilke; Alice Bot; Huub Jorna; Bob J Scholte; Hugo R de Jonge
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  14 in total

Review 1.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

2.  C-terminal proline deletions in KCNC3 cause delayed channel inactivation and an adult-onset progressive SCA13 with spasticity.

Authors:  Swati Khare; Kira Galeano; Yalan Zhang; Jerelyn A Nick; Harry S Nick; S H Subramony; Jacinda Sampson; Leonard K Kaczmarek; Michael F Waters
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

Review 3.  Kv3 Channels: Enablers of Rapid Firing, Neurotransmitter Release, and Neuronal Endurance.

Authors:  Leonard K Kaczmarek; Yalan Zhang
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

4.  Modeling Neurodegenerative Spinocerebellar Ataxia Type 13 in Zebrafish Using a Purkinje Neuron Specific Tunable Coexpression System.

Authors:  Kazuhiko Namikawa; Alessandro Dorigo; Marta Zagrebelsky; Giulio Russo; Toni Kirmann; Wieland Fahr; Stefan Dübel; Martin Korte; Reinhard W Köster
Journal:  J Neurosci       Date:  2019-03-12       Impact factor: 6.167

5.  Kv3.3 Channels Bind Hax-1 and Arp2/3 to Assemble a Stable Local Actin Network that Regulates Channel Gating.

Authors:  Yalan Zhang; Xiao-Feng Zhang; Matthew R Fleming; Anahita Amiri; Lynda El-Hassar; Alexei A Surguchev; Callen Hyland; David P Jenkins; Rooma Desai; Maile R Brown; Valeswara-Rao Gazula; Michael F Waters; Charles H Large; Tamas L Horvath; Dhasakumar Navaratnam; Flora M Vaccarino; Paul Forscher; Leonard K Kaczmarek
Journal:  Cell       Date:  2016-03-17       Impact factor: 41.582

Review 6.  Kv3.3 potassium channels and spinocerebellar ataxia.

Authors:  Yalan Zhang; Leonard K Kaczmarek
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

Review 7.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

8.  A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking.

Authors:  Swati Khare; Jerelyn A Nick; Yalan Zhang; Kira Galeano; Brittany Butler; Habibeh Khoshbouei; Sruti Rayaprolu; Tyisha Hathorn; Laura P W Ranum; Lisa Smithson; Todd E Golde; Martin Paucar; Richard Morse; Michael Raff; Julie Simon; Magnus Nordenskjöld; Karin Wirdefeldt; Diego E Rincon-Limas; Jada Lewis; Leonard K Kaczmarek; Pedro Fernandez-Funez; Harry S Nick; Michael F Waters
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

9.  Infant and adult SCA13 mutations differentially affect Purkinje cell excitability, maturation, and viability in vivo.

Authors:  Jui-Yi Hsieh; Brittany N Ulrich; Fadi A Issa; Meng-Chin A Lin; Brandon Brown; Diane M Papazian
Journal:  Elife       Date:  2020-07-09       Impact factor: 8.140

10.  Functional analysis helps to define KCNC3 mutational spectrum in Dutch ataxia cases.

Authors:  Anna Duarri; Esther A R Nibbeling; Michiel R Fokkens; Michel Meijer; Melissa Boerrigter; Corien C Verschuuren-Bemelmans; Berry P H Kremer; Bart P van de Warrenburg; Dennis Dooijes; Erik Boddeke; Richard J Sinke; Dineke S Verbeek
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.